Download PDF Download PDF

European Journal of Medicinal Chemistry

Publication date: 2018-01-01
Volume: 144 Pages: 93 - 103
Publisher: Elsevier

Author:

Plebanek, Elzbieta
Lescrinier, Eveline ; Andrei, Graciela ; Snoeck, Robert ; Herdewijn, Piet ; De Jonghe, Steven

Keywords:

Science & Technology, Life Sciences & Biomedicine, Chemistry, Medicinal, Pharmacology & Pharmacy, Emimycin, Nucleoside, Antiviral, Pyrazine, FAVIPIRAVIR T-705, DEOXYURIDINE, ANALOGS, CANCER, Antiviral Agents, Cell Line, Herpes Simplex, Herpesvirus 1, Human, Herpesvirus 3, Human, Humans, Nucleosides, Pyrazines, Varicella Zoster Virus Infection, Virus Replication, 0304 Medicinal and Biomolecular Chemistry, 0305 Organic Chemistry, 1115 Pharmacology and Pharmaceutical Sciences, Medicinal & Biomolecular Chemistry, 3214 Pharmacology and pharmaceutical sciences, 3404 Medicinal and biomolecular chemistry, 3405 Organic chemistry

Abstract:

The synthesis of emimycin, 5-substituted emimycin analogues and the corresponding ribo- and 2'-deoxyribonucleoside derivatives is described. Emimycin, its 5-substituted congeners and the ribonucleoside derivatives are completely devoid of antiviral activity against RNA viruses. In contrast, some of the 2'-deoxyribosyl emimycin derivatives are potent inhibitors of the replication of herpes simplex virus-1 and varicella-zoster virus, lacking cytotoxicity.